LCBDE及ERCP治疗胆总管结石后结石复发风险因素

doi:10.3969/j.issn.1009-976X.2023.04.012

摘要/Abstract

摘要： 胆总管结石是肝胆外科最常见的良性疾病之一,多以外科手术治疗为主,术后的复发率为4%~25%。近年来,复发率有上涨的趋势,因此,防止胆总管结石术后复发并了解其危险因素就成为了临床医师必须要解决的问题。经内镜逆行胰胆管造影胆管取石术（ERCP）以及腹腔镜下胆总管探查取石术（LCBDE）已经成为胆总管结石的最常用外科治疗手段。两种术式的结石复发危险因素存在相同点,也存在不同点,同时影响结石复发的原因并不是单一因素所致,而是多因素共同作用导致的。本文通过综合分析国内外有关两种术式术后结石复发危险因素的不同,旨在从外科医师的角度上探究如何最大程度上降低结石复发的概率,为临床医师提供参考。

关键词: LCBDE, ERCP, 胆总管结石, 复发因素

Abstract: Common bile duct stones are one of the most common benign diseases in hepatobiliary surgery and are mostly treated surgically, with a recurrence rate of 4%-25% after surgery. In recent years, the recurrence rate has been on the rise. Therefore, preventing the recurrence of common bile duct stones after surgery and understanding their risk factors becomes a problem that clinicians must address. Endoscopic retrograde cholangiopancreatography （ERCP） and laparoscopic common bile duct exploration （LCBDE） have become the most common surgical treatment for common bile duct stones. The two procedures have similarities and differences in the risk factors for stone recurrence. And the causes of stone recurrence are not due to a single factor, but to a combination of factors. This paper aims to investigate how to minimize the probability of stone recurrence from the surgeon′s point of view and provide a reference for clinicians by synthesizing the differences in risk factors for stone recurrence after two types of surgery at home and abroad.

Key words: LCBDE, ERCP, common bile duct stones, recurrence factors

中图分类号:

R657.4

李鹏成, 于瀚翔, 脱红芳, 温军业, 王超超. LCBDE及ERCP治疗胆总管结石后结石复发风险因素[J]. 岭南现代临床外科, 2023, 23(04): 353-359.

LI Peng-cheng, YU Han-xiang, TUO Hong-fang, WEN Jun-ye, WANG Chao-chao. Risk factors for stone recurrence after LCBDE and ERCP for common bile duct stones[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 353-359.

参考文献

[1] 周京高,方仁桂,王学军,等. 腹腔镜胆道探查术在胆总管结石治疗中的应用[J].肝胆胰外科杂志, 2009, 21(1): 63-64.
[2] Tazuma S.Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)[J]. Best Pract Res Clin Gastroenterol, 2006, 20(6): 1075-1083.
[3] Bhattacharyya R.Re: Endoscopic large balloon sphincteroplasty is a useful, safe adjunct for difficult to treat choledocholithiasis[J]. ANZ J Surg, 2016, 86(12): 1068.
[4] Xie W, Yang T, Zhou X, et al.A nomogram for predicting stones recurrence in patients with bile duct stones undergoing laparoscopic common bile duct exploration[J]. Ann Gastroenterol Surg, 2022, 6(4): 543-554.
[5] Platt TE, Smith K, Sinha S, et al.Laparoscopic common bile duct exploration; a preferential pathway for elderly patients[J]. Ann Med Surg (Lond), 2018, 30: 13-17.
[6] Parra-Membrives P, Martínez-Baena D, Lorente-Herce JM, et al.Choledocholithiasis recurrence following laparoscopic common bile duct exploration[J]. Cir Esp (Engl Ed), 2019, 97(6): 336-342.
[7] Nzenza TC, Al-Habbal Y, Guerra GR, et al.Recurrent common bile duct stones as a late complication of endoscopic sphincterotomy[J]. BMC Gastroenterol, 2018, 18(1): 39.
[8] Park BK, Seo JH, Jeon HH, et al.A nationwide population-based study of common bile duct stone recurrence after endoscopic stone removal in Korea[J]. J Gastroenterol, 2018, 53(5): 670-678.
[9] Ding G, Cai W, Qin M.Single-stage vs. two-stage management for concomitant gallstones and common bile duct stones: a prospective randomized trial with long-term follow-up[J]. J Gastrointest Surg, 2014, 18(5): 947-951.
[10] 郭健童,苏树英,张耿,等. AMS、leptin、TG预测胆囊结石合并胆总管多发结石术后复发价值[J]. 分子诊断与治疗杂志, 2021, 13(10): 1569-1573.
[11] 雷正明,曾道炳,陈跃,等. 瘦素、胆囊收缩素、血脂与胆石类型关系探讨[J]. 中华肝胆外科杂志, 2007,13(4): 220-223.
[12] Jakobs R, Hartmann D, Kudis V, et al.Risk factors for symptomatic stone recurrence after transpapillary laser lithotripsy for difficult bile duct stones using a laser with a stone recognition system[J]. Eur J Gastroenterol Hepatol, 2006, 18(5): 469-473.
[13] Kiani Q, Farooqui F, Khan MS, et al.Association of Body Mass Index and Diet with Symptomatic Gall Stone Disease: A Case-Control Study[J]. Cureus, 2020, 12(3): e7188.
[14] Buch S, Schafmayer C, Völzke H, et al.A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease[J]. Nat Genet, 2007, 39(8): 995-999.
[15] Acalovschi M, Ciocan A, Mostean O, et al.Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones[J]. Eur J Intern Med, 2006, 17(7): 490-494.
[16] Rosmorduc O, Hermelin B, Boelle PY, et al.ABCB4 gene mutation-associated cholelithiasis in adults[J]. Gastroenterology, 2003, 125(2): 452-459.
[17] Baek YH, Kim HJ, Park JH, et al.Risk factors for recurrent bile duct stones after endoscopic clearance of common bile duct stones[J]. Korean J Gastroenterol, 2009, 54(1): 36-41.
[18] Lujian P, Xianneng C, Lei Z.Risk factors of stone recurrence after endoscopic retrograde cholangiopancreatography for common bile duct stones[J]. Medicine (Baltimore), 2020, 99(27): e20412.
[19] Konstantakis C, Triantos C, Theopistos V, et al.Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones[J]. World J Gastrointest Endosc, 2017, 9(1): 26-33.
[20] Deng F, Zhou M, Liu PP, et al.Causes associated with recurrent choledocholithiasis following therapeutic endoscopic retrograde cholangiopancreatography: A large sample sized retrospective study[J]. World J Clin Cases, 2019, 7(9): 1028-1037.
[21] Jeon J, Lim SU, Park CH, et al.Restoration of common bile duct diameter within 2 weeks after endoscopic stone retraction is a preventive factor for stone recurrence[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(3): 251-256.
[22] Li T, Wen J, Bie L K, et al.Long-term outcomes of endoscopic papillary balloon dilation for removal of bile duct stones in Billroth II gastrectomy patients[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(3): 257-262.
[23] Yoo ES, Yoo BM, Kim JH, et al.Evaluation of risk factors for recurrent primary common bile duct stone in patients with cholecystectomy[J]. Scand J Gastroenterol, 2018, 53(4): 466-470.
[24] Oak JH, Paik CN, Chung WC, et al.Risk factors for recurrence of symptomatic common bile duct stones after cholecystectomy[J]. Gastroenterol Res Pract, 2012, 2012:417821.
[25] Keizman D, Shalom MI, Konikoff FM.An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction[J]. Surg Endosc, 2006, 20(10): 1594-1599.
[26] Leung JW, Sung JY, Costerton JW.Bacteriological and electron microscopy examination of brown pigment stones[J]. J Clin Microbiol, 1989, 27(5): 915-921.
[27] Matyjas T, Kaczka K, Witas H, et al.Cholelithiasis-always infected?[J]. Pol Przegl Chir, 2017, 89(3): 23-26.
[28] Lee J, Jeong HJ, Kim H, et al.The Role of the Bile Microbiome in Common Bile Duct Stone Development[J]. Biomedicines, 2023, 11(8): 2124.
[29] Li W, Ren A, Qin Q, et al.Causal associations between human gut microbiota and cholelithiasis: a mendelian randomization study[J]. Front Cell Infect Microbiol, 2023, 13:1169119.
[30] Stewart L, Ponce R, Oesterle AL, et al.Pigment gallstone pathogenesis: slime production by biliary bacteria is more important than beta-glucuronidase production[J]. J Gastrointest Surg, 2000, 4(5): 547-553.
[31] 孟翔凌,汪正广,韩文秀,等. 幽门螺杆菌感染与肝内外胆管结石术后胆管炎及结石复发关系的研究[J]. 肝胆外科杂志, 2009, 17(1): 50-53.
[32] 孙权,刘志苏,徐旭东. 应用套式PCR技术对胆色素结石成因的研究[J].中华普通外科杂志, 2005, 20(9): 601-602.
[33] Hill PA, Harris RD.Clinical Importance and Natural History of Biliary Sludge in Outpatients[J]. J Ultrasound Med, 2016, 35(3): 605-610
[34] Chen B, Fu SW, Lu L, et al.A Preliminary Study of Biliary Microbiota in Patients with Bile Duct Stones or Distal Cholangiocarcinoma[J]. Biomed Res Int, 2019, 2019: 1092563.
[35] Chae MK, Lee SH, Joo KR.Assessment of the possible risk factors for primary common bile duct stone recurrence after cholecystectomy[J]. Surg Endosc, 2021,35(12):6497-6504.
[36] Sugiyanna M, Suzuki Y, Abe N, et al.Endoscopic retreatment of recurrent choledocholithiasis after sphincterotomy[J]. Gut, 2004, 53(12): 1856-1859.
[37] Rudling M, Laskar A, Straniero S.Gallbladder bile supersaturated with cholesterol in gallstone patients preferentially develops from shortage of bile acids[J]. J Lipid Res, 2019, 60(3): 498-505.
[38] Mchenry L, Lehman G.Difficult bile duct stones[J]. Curr Treat Options Gastroenterol, 2006, 9(2): 123-132.
[39] Bergman JJ, Van Berkel AM, Groen AK, et al.Biliary manometry, bacterial characteristics, bile composition, and histologic changes fifteen to seventeen years after endoscopic sphincterotomy[J]. Gastrointest Endosc, 1997, 45(5): 400-405.
[40] Li T, Wen J, Bie L, et al.Comparison of the Long-Term Outcomes of Endoscopic Papillary Large Balloon Dilation Alone versus Endoscopic Sphincterotomy for Removal of Bile Duct Stones[J]. Gastroenterol Res Pract, 2018, 2018: 6430701.
[41] Sugiyama M, Atomi Y.Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: long-term (more than 10 years) follow-up study[J]. Am J Gastroenterol, 2002, 97(11): 2763-2767.
[42] Li S, Su B, Chen P, et al.Risk factors for recurrence of common bile duct stones after endoscopic biliary sphincterotomy[J]. J Int Med Res, 2018, 46(7): 2595-2605.
[43] Costamagna G, Tringali A, Shah SK, et al.Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence[J]. Endoscopy, 2002, 34(4): 273-279.
[44] 朱杰高,张忠涛,韩威,等. 经胆囊管途径探查取石失败后的应对策略[J].中华肝胆外科杂志, 2014(3): 224-226.
[45] Williams JA, Treacy PJ, Sidey P, et al.Primary duct closure versus T-tube drainage following exploration of the common bile duct[J]. Aust NZJ Surg, 1994, 64(12): 823-826.
[46] Seo DB, Bang BW, Jeong S, et al.Does the bile duct angulation affect recurrence of choledocholithiasis?[J]. World J Gastroenterol, 2011, 17(36): 4118-4123.
[47] Jakobs R, Hartmann D, Kudis V, et al.Risk factors for symptomatic stone recurrence after transpapillary laser lithotripsy for difficult bile duct stones using a laser with a stone recognition system[J]. Eur J Gastroenterol Hepatol, 2006, 18(5): 469-473.
[48] Escarce JJ, Shea JA, Chen W, et al.Outcomes of open cholecystectomy in the elderly: a longitudinal analysis of 21, 000 cases in the prelaparoscopic era[J]. Surgery, 1995, 117(2): 156-164.
[49] Lee SJ, Choi IS, Moon JI.Comparison of Laparoscopic Common Bile Duct Exploration Combine with Cholecystectomy and Laparoscopic Cholecystectomy with Preoperative Endoscopic Sphincterotomy: In Terms of Surgical Outcomes and Recurrences[J]. HPB, 2021, 23: S90-S91.
[50] Choi HH, Lee H, Park DJ, Lee H.Risk factors for recurrence following common bile duct exploration for choledocholithiasis[J]. J Minim Invasive Surg, 2021,24(1):43-50.
[51] 赵文超,刘彻,赖成思,等. ERCP联合LC与LC联合LCBDE治疗胆囊结石合并胆管结石的远期疗效比较[J]. 转化医学杂志, 2020, 9(5): 291-295.
[52] Park SY, Hong TH, Lee SK, et al.Recurrence of common bile duct stones following laparoscopic common bile duct exploration: a multicenter study[J]. J Hepatobiliary Pancreat Sci, 2019, 26(12): 578-582.
[53] 胡松,房姝妍,靳广甫,等. 胆总管结石取石术后复发的临床特征及其危险因素分析[J].现代生物医学进展, 2017, 17(22): 4299-4302.
[54] Bove A, Bongarzoni G, Palone G, et al.Why is there recurrence after transcystic laparoscopic bile duct clearance? Risk factor analysis[J]. Surg Endosc, 2009, 23(7): 1470-1475.
[55] Paganini AM, Lezoche E.Follow-up of 161 unselected consecutive patients treated laparoscopically for common bile duct stones[J]. Surg Endosc, 1998, 12(1): 23-29.
[56] Wang HH, Portincasa P, Liu M, et al.Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation[J]. Adv Ther, 2023, 40(3): 743-768.
[57] Keizman D, Ish-Shalom M, Konikoff FM.The clinical significance of bile duct sludge: is it different from bile duct stones?[J]. Surg Endosc, 2007, 21(5): 769-773.
[58] Wang HH, Portincasa P, Liu M, et al.Similarities and differences between biliary sludge and microlithiasis: Their clinical and pathophysiological significances[J]. Liver Res, 2018, 2(4): 186-199.
[59] Lavoie B, Nausch B, Zane EA, et al.Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease[J]. Neurogastroenterol Motil, 2012, 24(7): e313-e324.
[60] Zhao J, Kim H, Han Y, et al.Chronological changes in epidemiologic features of patients with gallstones over the last 20 years in a single large-volume Korean center[J]. Ann Surg Treat Res, 2019, 97(3): 136-141.
[61] Nogueiro J, Santos-Sousa H, Ribeiro M, et al.Incidence of symptomatic gallstones after bariatric surgery: the impact of expectant management[J]. Langenbecks Arch Surg, 2023, 408(1): 160.
[62] Leclerc J, Vermaut C, Buisine MP.Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors[J]. Cancers (Basel), 2021, 13(3): 467.
[63] 杨瑞军,白筱晞. 腹腔镜胆囊切除术治疗急性结石性胆囊炎的效果及对炎症因子及血清淀粉酶水平的影响[J].贵州医药, 2020, 44(4): 579-580.
[64] 翁宇航,杨永峰. ABCB4突变基因型与表型的相关性[J].临床肝胆病杂志, 2021, 37(11): 2723-2727.
[65] 杨六成,黄宝裕,薛桂芳,等. 华支睾吸虫感染与肝胆胰外科疾病的关系(附650例临床分析)[J].中华肝胆外科杂志, 2004, 10(3): 24-25.
[66] Moriya K, Todoroki T, Tsutsumi T, et al.Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans[J].Biochem Biophys Res Commun, 2001, 281(5): 1207-1212.
[67] Keizman D, Ish Shalom M, Konikoff FM.Recurrent symptomatic common bile duct stones after endoscopic stone extraction in elderly patients[J]. Gastrointest Endosc, 2006, 64(1): 60-65.
[68] Cuevas A, Miquel J F, Reyes MS, et al.Diet as a risk factor for cholesterol gallstone disease[J]. J Am Coll Nutr, 2004, 23(3): 187-196.
[69] Ueno N, Ozawa Y, Aizawa T.Prognostic factors for recurrence of bile duct stones after endoscopic treatment by sphincter dilation[J]. Gastrointest Endosc, 2003, 58(3): 336-340.
[70] Li X, Zhu K, Zhang L, et al.Periampullary diverticulum may be an important factor for the occurrence and recurrence of bile duct stones[J]. World J Surg, 2012, 36(11): 2666-2669.
[71] 吴以龙, 陈丹凤, 李莉, 等. 无痛ERCP治疗胆总管结石86例临床分析[J].中国消化内镜, 2009, 3(4): 30-32.